Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,771 | 7,175 | 4,145 | 603 | 50 |
| Receivables | 277 | 89 | 149 | N/A | N/A |
| Inventories | 372 | 119 | 37 | N/A | N/A |
| Other current assets | 110 | 135 | 0 | 0 | 0 |
| TOTAL | $16,096 | $7,575 | $4,350 | $603 | $50 |
| Non-Current Assets | |||||
| PPE Net | 1,280 | 1,015 | 1,327 | N/A | N/A |
| Investments And Advances | 6,886 | 5,106 | 0 | 943 | 1,614 |
| Intangibles | 18,836 | 3,901 | 941 | 0 | 0 |
| Other Non-Current Assets | 588 | 0 | 134 | 0 | 0 |
| TOTAL | $27,590 | $10,022 | $2,402 | $943 | $1,614 |
| Total Assets | $43,685 | $17,597 | $6,752 | $1,545 | $1,664 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 19 |
| Accounts payable and accrued liabilities | 463 | 282 | 24 | 513 | 556 |
| Accrued Expenses | 2,074 | 504 | 98 | 982 | 542 |
| Other current liabilities | 725 | 251 | 474 | 100 | 153 |
| TOTAL | $4,076 | $2,202 | $595 | $1,971 | $1,605 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 376 | 335 |
| Other Non-Current Liabilities | 453 | 0 | 0 | 0 | 0 |
| TOTAL | $453 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,529 | $2,202 | $595 | $1,971 | $1,605 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,995 | 7,569 | 5,362 | 156,347 | 150,781 |
| Common Shares | 11 | 7 | 4 | 2 | 5,672 |
| Retained earnings | -37,891 | -22,416 | -8,619 | -6,593 | -5,613 |
| Other shareholders' equity | 1,568 | -58 | 62 | -23 | 0 |
| TOTAL | $39,156 | $15,395 | $6,156 | $-426 | $59 |
| Total Liabilities And Equity | $43,685 | $17,597 | $6,752 | $1,545 | $1,664 |